Home
About
Overview
Sharing Data
ORCID
Help
History (49)
Speech recognition and temporal processing in middle-aged women.
Cloacin
Serum cytokine profiles associated with specific adjuvants used in a DNA prime-protein boost vaccination strategy.
Transitions, Risks, and Actions in Coronary Events--Center for Outcomes Research and Education (TRACE-CORE): design and rationale.
Hypertrophic cardiomyopathy with longevity to 90 years or older.
See All 49 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Hypertrophic cardiomyopathy with longevity to 90 years or older.
Maron BJ, Casey SA, Haas TS, Kitner CL, Garberich RF, Lesser JR. Hypertrophic cardiomyopathy with longevity to 90 years or older. Am J Cardiol. 2012 May 01; 109(9):1341-7.
View in:
PubMed
subject areas
Age Factors
Age of Onset
Aged
Aged, 80 and over
Cardiomyopathy, Hypertrophic
Death, Sudden, Cardiac
Disease Progression
Female
Follow-Up Studies
Humans
Male
Middle Aged
Minnesota
Prognosis
Retrospective Studies
Risk Factors
Survival Rate
Time Factors
authors with profiles
Barry J Maron MD